BeStock  
Stocks › Medical Devices › NEOG

Neogen NEOG

US equityMarket cap rank #2600Medical Devices
$10.55 −$0.30 (-2.77%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.40 -1.42%
Open$10.76
Prev close$10.85
Day range$10.42 – $10.94
Volume3.04M
Market cap$2.30B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q1, ended Aug 2026

Revenue$222.80M+6.5% YoY
Operating profit-$1.80M+88.8% YoY
Net profit-$11.90M-132.8% YoY
Diluted EPS-$0.05-129.4% YoY
Free cash flow$4.70M+135.6% YoY
Operating cash flow$12.90M

Revenue, last 8 quarters

$231.3MNov '24$221.0MFeb '25$225.5MMay '25$209.2MAug '25$224.7MNov '25$211.2MFeb '26$225.3MMay '26$222.8MAug '26

Net profit, last 8 quarters

$-456.3MNov '24$-10.9MFeb '25$-612.2MMay '25$36.3MAug '25$-15.9MNov '25$-17.0MFeb '26$-11.3MMay '26$-11.9MAug '26

Diluted EPS by quarter

-2.10Nov '24-0.05Feb '25-2.82May '250.17Aug '25-0.07Nov '25-0.08Feb '26-0.05May '26-0.05Aug '26

Free cash flow by quarter

$23.1MNov '24$-13.4MFeb '25$300.0KMay '25$-13.2MAug '25$7.8MNov '25$11.1MFeb '26$26.2MMay '26$4.7MAug '26

Annual revenue

$468.5MFY21$527.2MFY22$822.4MFY23$924.2MFY24$894.7MFY25$870.4MFY26

Profitability & balance sheet

Gross margin47.4%
Operating margin-0.8%
Net margin-6.3%
Return on equity-2.7%
Return on assets-1.7%
Return on invested capital-0.3%
Current ratio3.90
Liabilities / assets36.8%
Cash & investments$172.00M
Total debt$774.20M
Net cash (debt)-$602.20M
Free cash flow / sales5.6%

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Food Safety$169.70M 73.4%
  • Animal Safety$61.60M 26.6%

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Revenue as Reported $222.80M $870.40M $225.30M $211.20M $224.69M
Total Operating Revenue $222.80M $870.40M $225.30M $211.20M $224.69M
Cost of Revenue $117.30M $461.90M $117.50M $112.20M $118.01M
Gross Profit $105.50M $408.50M $107.80M $99.00M $106.68M
Operating Expense $107.30M $430.10M $104.70M $102.30M $112.06M
Selling and Admin Expenses $100.80M $411.70M $99.80M $98.50M $107.50M
-Selling & Marketing Expense $41.50M $166.60M $41.10M $38.20M $42.29M
-General & Admin Expense $59.30M $245.10M $58.70M $60.30M $65.21M
Research & Development $6.50M $18.40M $4.90M $3.80M $4.56M
Operating Profit -$1.80M -$21.60M $3.10M -$3.30M -$5.38M
Net Non-Operating Interest Income (Expense) -$13.80M -$57.60M -$13.90M -$13.90M -$14.26M
Non-Operating Interest Expense $13.80M $57.60M $13.90M $13.90M $14.85M
Other Income (Expense) $700,000.00 $70.20M -$1.30M -$3.10M -$731,000.00
Special Income (Charges) -$400,000.00 $76.40M $0.00 $0.00 $0.00
-Gain on Sale Of Business -$400,000.00 $76.40M $0.00 $0.00 $0.00
Other Non-Operating Income (Expenses) $1.10M -$6.20M -$1.30M -$3.10M -$731,000.00
Pretax Profit -$14.90M -$9.00M -$12.10M -$20.30M -$20.36M
Tax -$3.00M -$1.10M -$800,000.00 -$3.30M -$4.44M
Net Profit -$11.90M -$7.90M -$11.30M -$17.00M -$15.92M
Profit from Continuing Operations -$11.90M -$7.90M -$11.30M -$17.00M -$15.92M
Net Income to Parent Company -$11.90M -$7.90M -$11.30M -$17.00M -$15.92M
Net Income to Common Stockholders -$11.90M -$7.90M -$11.30M -$17.00M -$15.92M
Basic EPS -$0.05 -$0.04 -$0.05 -$0.08 -$0.07
Diluted EPS -$0.05 -$0.04 -$0.05 -$0.08 -$0.07
-Less:Impairment of Capital Assets – $0.00 $0.00 $0.00 $0.00
Non-Operating Interest Income – – – – $592,000.00

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $3.30B $3.35B $3.35B $3.36B $3.36B
Total Current Assets $582.50M $604.60M $604.60M $590.00M $574.58M
Cash and Cash Equivalents & Short-Term Investments $172.00M $185.50M $185.50M $159.90M $145.34M
-Cash and Cash Equivalents $172.00M $185.50M $185.50M $159.90M $145.34M
Receivables $136.20M $146.80M $146.80M $137.10M $132.00M
-Accounts Receivable $136.20M $146.80M $146.80M $137.10M $132.00M
Inventory $146.10M $144.30M $144.30M $161.70M $162.77M
Other Current Assets $57.80M $60.00M $60.00M $63.10M $57.71M
Total Non-Current Assets $2.72B $2.74B $2.74B $2.77B $2.79B
Net PPE $348.90M $346.40M $346.40M $347.60M $347.46M
-Gross PPE $348.90M $497.00M $497.00M $347.60M $347.46M
Goodwill and Other Intangible Assets $2.34B $2.37B $2.37B $2.39B $2.41B
-Goodwill $1.05B $1.05B $1.05B $1.05B $1.05B
-Other Intangible Assets $1.30B $1.32B $1.32B $1.34B $1.36B
Other Non-Current Assets $28.40M $29.80M $29.80M $31.80M $32.50M
Total Liabilities $1.22B $1.25B $1.25B $1.26B $1.26B
Total Current Liabilities $149.50M $158.20M $158.20M $150.60M $147.05M
Payables $86.30M $86.30M $86.30M $85.10M $72.00M
-Accounts Payable $77.60M $79.10M $79.10M $75.20M $63.04M
-Total Tax Payable $8.70M $7.20M $7.20M $9.90M $8.96M
Current Accrued Expenses $3.40M $11.00M $11.00M $3.50M $11.02M
Current Deferred Liabilities $3.60M $3.60M $3.60M $3.90M $3.87M
Other Current Liabilities $34.30M $30.50M $30.50M $34.60M $39.88M
Total Non-Current Liabilities $1.07B $1.09B $1.09B $1.11B $1.11B
Long Term Debt and Capital Lease Obligation $774.20M $793.70M $793.70M $793.30M $792.93M
-Long Term Debt $774.20M $793.70M $793.70M $793.30M $792.93M
-Long Term Capital Lease Obligation $0.00 $0.00 $0.00 $0.00 $0.00
Non-Current Deferred Liabilities $251.40M $257.60M $257.60M $269.20M $273.95M
Other Non-Current Liabilities $41.70M $43.60M $43.60M $43.50M $41.54M
Total Equity $2.09B $2.09B $2.09B $2.10B $2.10B
Stockholders' Equity $2.09B $2.09B $2.09B $2.10B $2.10B
Capital Stock $34.90M $34.80M $34.80M $34.80M $34.80M
-Common Stock $34.90M $34.80M $34.80M $34.80M $34.80M
-Preferred Stock $0.00 $0.00 $0.00 – $0.00
Additional Paid-In Capital $2.62B $2.62B $2.62B $2.61B $2.61B
Retained Earnings -$556.20M -$544.30M -$544.30M -$533.00M -$516.01M
Gains/Losses Not Affecting Retained Earnings -$12.30M -$13.60M -$13.60M -$12.50M -$25.61M
-Accumulated Depreciation – -$150.60M -$150.60M – –

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow $12.90M $83.20M $30.20M $22.70M $19.50M
Net cash flow from continuing operations $12.90M $83.20M $30.20M $22.70M $19.50M
Net Income from Continuing Operations -$11.90M -$7.90M -$11.30M -$17.01M -$15.89M
Gain/Loss from Continuing Operations $600,000.00 -$74.80M $0.00 $231,000.00 $269,000.00
Depreciation & Depletion & Amortization $30.40M $121.90M $35.00M $28.92M $27.48M
Deferred Tax -$5.20M -$24.30M -$8.80M -$4.27M -$5.43M
Other Non-Cash Items $1.00M $2.80M $1.50M $706,000.00 $494,000.00
Change in Working Capital -$5.10M $52.10M $10.80M $13.03M $8.27M
-Change in Receivables $10.40M $6.80M -$9.80M $5.25M -$6.25M
-Change in Inventory -$3.80M $38.20M $16.70M $4.80M $18.71M
-Change in Prepaid Assets $1.70M -$6.70M $3.30M -$5.57M -$5.63M
-Change in Payables and Accrued Expense -$8.80M $19.80M $6.90M $8.10M -$1.90M
-Change In Other Working Capital -$4.60M -$6.00M -$6.30M $452,000.00 $3.35M
Net cash flow from investing -$8.20M $70.50M -$4.00M -$11.56M -$11.64M
Net Cash Flow from Continuing Investing Activities -$8.20M $70.50M -$4.00M -$11.56M -$11.64M
Net PPE Purchase and Sale -$8.20M -$51.20M -$4.00M -$11.53M -$11.67M
Net Business Purchase and Sale $0.00 $121.70M $0.00 -$24,000.00 $24,000.00
Financing Cash Flow -$19.00M -$99.40M -$300,000.00 $744,000.00 -$444,000.00
Net Cash Flow from Continuing Financing Activities -$19.00M -$99.40M -$300,000.00 $744,000.00 -$444,000.00
Net Issuance Payments Of Debt -$20.00M -$100.10M $0.00 -$25,000.00 $25,000.00
Proceeds from Stock Option Exercised $2.20M $1.60M -$100,000.00 $822,000.00 -$22,000.00
Net Other Financing Charges -$1.20M -$900,000.00 -$200,000.00 -$53,000.00 -$447,000.00
Ending Cash Balance $172.00M $185.50M $185.50M $159.90M $145.34M
Net Change in Cash -$14.30M $54.30M $25.90M $11.89M $7.41M
Beginning Cash Balance $185.50M $129.00M $159.90M $145.34M $138.80M
Effect of Exchange Rate Changes $800,000.00 $2.20M -$300,000.00 $2.67M -$873,000.00
Free Cash Flow $4.70M $31.90M $26.20M $11.07M $7.83M
Net Investment Purchase and Sale – $0.00 $0.00 $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on NEOG.

Sign in to join the discussion.

Scroll to Top